VCR ventracor limited

sunshine

  1. 4,131 Posts.
    Sunshine Heart gains two experts for US C-Pulse trial
    09:02, Thursday, February 22, 2007
    Sydney - Thursday - February 22: (RWE Aust Business News) -
    Sunshine Heart (ASX:SHC) said Dr William T Abraham of Ohio State
    University and Dr Patrick M McCarthy of Northwestern University, Chicago,
    have agreed to become the co-principal investigators for the C-Pulse
    feasibility trial the United States.
    The appointment of Drs Abraham and McCarthy continues Sunshine
    Heart's progress towards commencing the multi-centre trial during 2007
    following the positive meeting with the FDA (United States Food and Drug
    Administration).
    Sunshine Heart shares were last traded at 20c.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.